Lung Cancer

1

Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer

Ager, Bryan J., Wells, Stacey M., Gruhl, Joshua D., Stoddard, Gregory J., Tao, Randa, Kokeny, Kristine E., Hitchcock, Ying J.

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 803 KB

english, 2019

2

Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options

Jurmeister, Philipp, Vollbrecht, Claudia, Behnke, Anke, Frost, Nikolaj, Arnold, Alexander, Treue, Denise, Rückert, Jens-Carsten, Neudecker, Jens, Schweizer, Leonille, Klauschen, Frederick, Horst, Davi

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 2.81 MB

english, 2019

3

Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)

Stamatis, Georgios, Leschber, Gunda, Schwarz, Birte, Brintrup, Diana Lütke, Ose, Claudia, Weinreich, Gerhard, Passlick, Bernward, Hecker, Erich, Kugler, Christian, Dienemann, Hendrik, Krbek, Thomas, E

Journal:

Lung Cancer

Year:

2019

File:

PDF, 535 KB

2019

4

Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer

Park, Seong Yong, Byun, Go Eun, Lee, Chang Young, Lee, Jin Gu, Kim, Dae Joon, Paik, Hyo Chae, Chung, Kyoung Young

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 782 KB

english, 2019

5

A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302)

Asahina, Hajime, Oizumi, Satoshi, Takamura, Kei, Harada, Toshiyuki, Harada, Masao, Yokouchi, Hiroshi, Kanazawa, Kenya, Fujita, Yuka, Kojima, Tetsuya, Sugaya, Fumiko, Tanaka, Hisashi, Honda, Ryoichi, K

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 352 KB

english, 2019

6

Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experience

Chiappetta, Marco, Zanfrini, Edoardo, Giraldi, Luca, Mastromarino, Maria Giovanna, Petracca-Ciavarella, Leonardo, Nachira, Dania, Congedo, Maria Teresa, Aprile, Vittorio, Ambrogi, Marcello Carlo, Lucc

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 971 KB

english, 2019

7

Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy

Shen, Chia-I, Huang, Hsu-Ching, Chiang, Chi-Lu, Luo, Yung-Hung, Shiao, Tsu-Hui, Chiu, Chao-Hua

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 1.74 MB

english, 2019

8

Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors

Puliti, Donella, Mascalchi, Mario, Carozzi, Francesca Maria, Carrozzi, Laura, Falaschi, Fabio, Paci, Eugenio, Lopes Pegna, Andrea, Aquilini, Ferruccio, Barchielli, Alessandro, Bartolucci, Maurizio, Gr

Journal:

Lung Cancer

Year:

2019

File:

PDF, 858 KB

2019

9

Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater

She, Longjiang, Hu, Huabin, Liao, Mengting, Xia, Xuefeng, Shi, Yin, Yao, Linli, Ding, Dong, Zhu, Youwen, Zeng, Shan, Shen, Liangfang, Huang, Jin, Carbone, David P.

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 562 KB

english, 2019

10

Thorough survey and analysis of pulmonary lymphoepithelioma-like carcinoma in Macau and multimodality treatment for advanced disease

Zhou, Na, Lin, Yi, Peng, Xianghong, Wang, Yingyi, Wang, Yuzhou

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 1.21 MB

english, 2019

11

Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis

Eichhorn, F., Klotz, L.V., Muley, T., Kobinger, S., Winter, H., Eichhorn, M.E.

Journal:

Lung Cancer

Year:

2019

Language:

english

File:

PDF, 902 KB

english, 2019

12

Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater

She, Longjiang, Hu, Huabin, Liao, Mengting, Xia, Xuefeng, Shi, Yin, Yao, Linli, Ding, Dong, Zhu, Youwen, Zeng, Shan, Shen, Liangfang, Huang, Jin, Carbone, David P.

Journal:

Lung Cancer

Year:

2019

File:

PDF, 562 KB

2019

13

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Hermans, B.C.M., Derks, J.L., Thunnissen, E., van Suylen, R.J., den Bakker, M.A., Groen, H.J.M., Smit, E.F., Damhuis, R.A., van den Broek, E.C., Ruland, A., Speel, E.J.M., Dingemans, A.M.C.

Journal:

Lung Cancer

Year:

2019

File:

PDF, 2.31 MB

2019

14

Editorial Board

Journal:

Lung Cancer

Year:

2019

File:

PDF, 87 KB

2019

15

Volume 138

Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer

Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options

Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)

Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer

A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302)

Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experience

Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy

Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors

Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater

Thorough survey and analysis of pulmonary lymphoepithelioma-like carcinoma in Macau and multimodality treatment for advanced disease

Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis

Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Editorial Board

Contents